Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Telmisartan + Amlodipine, Atc C09db04 For The Period 03/01/2023 - 02/28/2025
Deadline - Jan 05, 2025
Authority Name - login to view
Product classification - Medical solutions
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 483519323
Document Type - Tender Notices
Description - Contract notice: Conclusion of a non-exclusive discount agreement according to § 130a para. 8 sgb v on the active ingredient telmisartan + amlodipine, atc c09db04 for the period 03/01/2023 - 02/28/20 25 § 130a paragraph 8 sgb v enables the health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs to be dispensed at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, a regular process of active substance-related, formal award procedures takes place accord
Gt Ref Id - 483519323
Deadline - Jan 05, 2025
Documents :
Soft Copy - View
Why Us
2,00,000 +
Users
190 +
Countries Covered
1,00,000 +
Agencies Tracked
25,000 +
Notices Daily
50 Million +
Database